Showing results (1-10 of 26) with videos related to
Sort By:
Pageof 3
BMC Cancer|September 11, 2019
LETM1 is a potential biomarker of prognosis in lung non-small cell carcinomaLongzhen Piao, Zhaoting Yang, Ying Feng, et al.International Journal of Clinical and Experimental Pathology|January 2, 2016
LETM1 overexpression is correlated with the clinical features and survival outcome of breast cancerNan Li, Yahui Zheng, Chouhui Xuan, et al.Frontiers in Oncology|March 20, 2023
Case report and literature review: PET/CT in the evaluation of response to treatment of liver metastasis from colorectal cancer with DEBIRI-TACELan Jin, Wuyun Hu, Teng Li, et al.Human Pathology|June 10, 2018
B7H4 is associated with stemness and cancer progression in esophageal squamous cell carcinomaLongzhen Piao, Zhaoting Yang, Jiajun Jin, et al.Histology and Histopathology|October 19, 2022
Downregulation of desmoglein 2 promotes EMT progression in gallbladder cancerLingLing Wang, You Lv, JinBin Li, et al.British Journal of Hospital Medicine (London, England : 2005)|August 30, 2024
Camrelizumab Combined with Apatinib for Portal Vein Tumor Thrombus in Advanced Hepatocellular Carcinoma: Two Case ReportsNing Chen, Lei Zhang, Aimei Gao, et al.Human Pathology|July 22, 2018
Identification of LETM1 as a marker of cancer stem-like cells and predictor of poor prognosis in esophageal squamous cell carcinomaZhaoting Yang, Weidong Ni, Chunai Cui, et al.Frontiers in Oncology|May 1, 2023
Case Report: PD-L1-negative advanced bladder cancer effectively treated with anlotinib and tislelizumab: A report of two casesTeng Li, Wuyun Hu, Lan Jin, et al.Molecular Medicine Reports|March 22, 2019
LETM1 is required for mitochondrial homeostasis and cellular viability (Review)Yuwen Li, Quangdon Tran, Robin Shrestha, et al.Journal of Hepatocellular Carcinoma|October 4, 2023
Modified Hepatic Arterial Infusion Chemotherapy Combined with Lenvatinib and Camrelizumab for Advanced HCC: Two Case ReportsYuan Tian, Wenbiao Jin, Honghua Sun, et al.Pageof 3